Physician profile
Carlos Porter
NPI 1013918242
$10,494.30
in general payments reported to CMS, 2019-2025
43 companies · $1,175 in 2025
The $1,175 reported for 2025 was more than what 89% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,871 · 2020: $666 · 2021: $1,187 · 2022: $1,997 · 2023: $1,385 · 2024: $1,213 · 2025: $1,175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,773.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,772.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,629.69 | 2019-2020 | |
| Abbvie INC. | $1,375.17 | 2021-2024 | |
| Nevro Corp. | $1,226.67 | 2019-2023 | Senza |
| Allergan, INC. | $842.96 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $823.71 | 2022-2025 | Airsupra, Breztri, Farxiga |
| Lilly USA, LLC | $560.97 | 2019-2024 | Mounjaro |
| Novo Nordisk INC | $511.26 | 2022-2025 | Rybelsus, Ozempic, Wegovy |
| Eisai INC. | $374.97 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $346.48 | 2021-2024 | |
| Canon Medical Systems USA, INC. | $328.83 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $267.65 | 2019-2021 | |
| Abbott Laboratories | $244.30 | 2019-2025 | Infinity, Proclaim, Freestyle Libre 3 |
| Amgen INC. | $222.93 | 2019-2022 | |
| Lundbeck LLC | $165.78 | 2023 | Vyepti |
| Amarin Pharma, INC. | $138.40 | 2019-2022 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carlos Porter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.